Sonova Holding AG, the parent company of Phonak, Unitron, Hansaton, Advanced Bionics, Lyric, and other hearing health brands, announced full-year results for the financial year ending March 31, 2012.

In total, Sonova reported record sales of CHF 1,619.8 million in fiscal 2011/12, an increase of 11.6% in local currencies and 0.2% in reported Swiss francs compared to the previous year.

The company’s report credits the successful launch of new Phonak Spice and Unitron Era platform based hearing instruments for contributing to the growth numbers. It also notes that introducing regular and substantial improvements in technology and products has allowed it to generate 71% of its total sales with hearing instruments that have been on the market for less than 2 years.

The hearing instruments segment recorded a growth rate of 9.7% in local currencies. The company also reported that it expects sales to grow in the range of 7-9% and EBITA in the range of 15-20% in local currencies for 2012/13.

Other highlights:

  • The EMEA region (Europe, Middle East, and Africa; excluding Switzerland) accounted for 39% of Group sales and performed very well as a result of increased demand and market share gains.
  • The United States accounted for 36% of total Group sales in 2011/12 and reported growth rates in the high single-digits.
  • The Group achieved good growth in the rest of Americas driven by increased demand for Sonova’s products in Brazil.
  • The Asia/Pacific region grew at above-average growth rates, in both the hearing instruments and hearing implants segment, and accounted for 10% of total sales.

More details on the earnings report are available here.

SOURCE: Sonova